Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
02-08

DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ slipped 1.69% to $8.13 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.36% to 19,523.40 and Dow Jones Industrial Average falling 0.99% to 44,303.40.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 65.93% short of its 52-week high of $23.86, which the company achieved on June 6th.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.25% to $153.12, Pfizer Inc. $(PFE)$ fell 0.35% to $25.74, and Merck & Co. Inc. $(MRK)$ fell 0.87% to $87.28.

Trading volume (2.7 M) remained 1.3 million below its 50-day average volume of 4.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 7, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 07, 2025 17:28 ET (22:28 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10